Triazole compounds as KSP inhibitors

Details for Australian Patent Application No. 2011239977 (hide)

Owner Novartis AG

Inventors Abrams, Tinya; Barsanti, Paul A.; Ding, Yu; Duhl, David; Han, Wooseok; Hu, Cheng; Pan, Yue

Agent Davies Collison Cave

Pub. Number AU-A-2011239977

PCT Pub. Number WO2011/128381

Priority 61/324,651 15.04.10 US

Filing date 13 April 2011

Wipo publication date 20 October 2011

International Classifications

C07D 249/08 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 Antineoplastic agents

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/128381 Priority application(s): WO2011/128381

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011239980-System for storing and transporting transporting containers

2011239974-Combination of a macrocyclic inhibitor of HCV, a non-nucleoside and a nucleoside